Tag: Health Care

Displaying 1 - 20 of 574 results.

Pages

Filtering by content type: Press Release

Following a public comment period, the Federal Trade Commission has approved a final order designed to remedy the anticompetitive effects resulting from Abbott’s $8.3 billion acquisition of Alere.
WHAT:The Federal Trade Commission will host a workshop, “Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics”. Acting FTC Chairman Maureen K. Ohlhausen and U.S. Food and Drug Commissioner Dr.
The staff of the Federal Trade Commission has issued an opinion advising Crouse Health Hospital that an exemption under the Non-Profit Institutions Act, or NPIA, applied to its proposal to sell discounted pharmaceutical products to the employees and retirees, as well as their dependents, of its...
Federal Trade Commission staff submitted a comment to the Department of Veterans Affairs (VA) in support of its proposed rule that would clarify that VA health care practitioners may provide telehealth services to beneficiaries notwithstanding any contrary state licensing laws, rules, or...
Federal Trade Commission staff has issued a public notice encouraging academic and industry research on the impact of certificates of public advantage (COPA) on prices, quality, access, and innovation for healthcare services.
Federal Trade Commission staff has submitted comments to Frank W. Berry, Commissioner of the Georgia Department of Community Health, supporting a Certificate of Need (CON) application filed by Lee County Medical Center.
The Federal Trade Commission has announced an agenda for its upcoming workshop on competition issues related to prescription drug markets. The workshop, titled “Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics,” will take place on November 8, 2017 at the FTC’s...
The Federal Trade Commission is seeking public comment on an application by Fresenius Medical Care AG & Co. KGaA to establish a new outpatient hemodialysis clinic.
The Federal Trade Commission will hold a workshop on November 8, 2017 entitled, “Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics.” Acting FTC Chairman Maureen K. Ohlhausen and U.S. Food and Drug Commissioner Dr. Scott Gottlieb will give the keynote addresses.
Abbott Laboratories and Alere Inc. have agreed to a divestiture of two point-of-care medical device products line in order to settle Federal Trade Commission charges that Abbott’s proposed $8.3 billion acquisition of Alere will cause harm to competition.Abbott is a global healthcare company that...
Integra LifeSciences Holdings Corp. and Johnson & Johnson have agreed to a divestiture of five neurosurgical medical device product lines to settle Federal Trade Commission charges that Integra’s proposed $1 billion acquisition of Johnson & Johnson’s Codman Neuro division would negatively...
Following a public comment period, the Federal Trade Commission has approved a final order designed to remedy the anticompetitive effects resulting from Baxter’s proposed $625 million acquisition of Claris’ injectable drugs business.
The Federal Trade Commission will participate in a Twitter chat hosted by the Centers for Disease Control. The chat will include tips about healthy contact lens wear and care habits. The FTC will also discuss consumers’ right under the Contact Lens Rule to get a copy of their prescription from...
Federal Trade Commission staff submitted an additional public comment to the Tennessee Department of Health that opposes issuing a certificate of public advantage (COPA) to Mountain States Health Alliance and Wellmont Health System that would allow the two companies to merge.
The Federal Trade Commission has approved a sublicense submitted by Mallinckrodt ARD Inc. granting West Therapeutic Development, LLC certain rights to develop and market the specialty drug Synacthen Depot in the United States.Synacthen Depot contains a synthetic version of adrenocorticotropic...
The Federal Trade Commission has authorized a federal court action to block Sanford Health’s proposed acquisition of Mid Dakota Clinic, alleging that the deal would violate antitrust law by significantly reducing competition for adult primary care physician services, pediatric services, obstetrics...
The Federal Trade Commission has closed its investigation of whether the Texas Medical Board violated federal antitrust law by adopting rules restricting the practice of telemedicine and telehealth in Texas. The Commission voted to close the investigation after Texas enacted a law that overrides...
A federal court has approved the divestiture of Saltzer Medical Group from Idaho-based St. Luke’s Health System as a result of the Federal Trade Commission’s successful challenge of St. Luke’s acquisition of Saltzer.
The Federal Trade Commission will host a workshop tomorrow in Washington, DC, to explore competition, innovation, and consumer protection issues raised by hearing health services and technology.The event is free and open to the public. It will be available via live webcast and live tweeted via...
The Federal Trade Commission has announced a final agenda for the Now Hear This: Competition, Innovation, and Consumer Protection Issues in Hearing Health Care workshop. The event will explore competition, innovation, and consumer protection issues raised by hearing health services and technology. 

Pages